Concepedia

Zhijun Xu

ZX

Statistics

Publications

16

Citations

846

H-Index

14

Active since

2009

Affiliations

Nanfang Hospital(Current)

Southern Medical University

University of Science and Technology of China

Zhejiang University

Second Affiliated Hospital of Zhejiang University

Zhijun Xu is an author at Nanfang Hospital specializing in medicine, oncology, and molecular oncology.

Publications per year

2009–2025

16

Publications

16

MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling

Chun-Cai Gu, Jianqun Cai, Zhijun Xu et al. · Cell Death and Disease · 2019 · 133 citations · Full text

Medicine, Molecular Biology, Oncology +17

Hsp90ab1 stabilizes LRP5 to promote epithelial–mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression

Huanan Wang, Guangxu Deng, Mei-Ling Ai et al. · Oncogene · 2018 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17

CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer

Zhijun Xu, Chun-Cai Gu, Xingxing Yao et al. · Cell Death and Disease · 2020 · 122 citations · Full text

Medicine, Cell Biology, Oncology +17

The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition

Jiaolong Shi, Fengping Li, Xingxing Yao et al. · Oncogene · 2018 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

VB12-Sericin-PBLG-IR780 Nanomicelles for Programming Cell Pyroptosis via Photothermal (PTT)/Photodynamic (PDT) Effect-Induced Mitochondrial DNA (mitoDNA) Oxidative Damage

Weihong Guo, Zhenhao Li, Huilin Huang et al. · ACS Applied Materials & Interfaces · 2022 · 72 citations

Pharmacy, Oncology, Pharmacology +17

1–5 of 16